European Medicines Agency-Committee for Advanced Therapies stakeholders workshop

• Date:
  Thursday, 12 January 2012, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

This one-day workshop is organised by the Committee for Advanced Therapies (CAT) as part of its effort to strengthen the dialogue with its stakeholders. The main aim of the workshop is to communicate the outcome of focus group meetings held in 2011. Attendees will have the opportunity to send questions to the organising committee in advance.

Documents

Agenda - Committee for Advanced Therapies stakeholders workshop

Reference Number: EMA/CAT/929342/2011

Programme - Focus groups: a model for a fruitful interaction between the Committee for Advanced Therapies and its stakeholders

Reference Number: EMA/CAT/27660/2012

Presentation - Committee for Advanced Therapies (CAT) interested parties focus groups: A new model for a fruitful interaction between CAT and its stakeholders

Presentation - Objectives of the focus group on non-clinical development of advanced-therapy medicinal products and outcome of discussions in 2011

Presentation - Possible scenarios to address issues in non-clinical studies for advanced-therapy medicinal products

Presentation - Session 1: List of Questions from Participants on non-clinical development of ATMPs

Presentation - Focus group: a better system to navigate guidelines on advanced-therapy medicinal products

Presentation - Interactive flowchart for gene-therapy guidelines

Questions on session 2: Focus group 'better system to navigate advanced-therapy-medicinal-product guidance documents

Presentation - Committee for Advanced Therapies interested parties focus group 3 on incentives for academia, hospitals and charities: Objectives and outcome of the focus group meeting in 2011

Presentation - Incentives for development of advanced-therapy medicinal products

Presentation - Improve certainty of regulatory outcome: An incentive identified by stakeholders to foster translation of research into commercial products: A small and medium-sized enterprise perspective

Presentation - Optimising resources

Presentation - Optimising resources: Incentives for academia, hospital and charities

Questions on session 3: Focus group 'incentives for academia, hospitals and charities developing advanced-therapy medicinal products'